HALOZYME THERAPEUTICS, INC. - Common Stock (HALO)

CUSIP: 40637H109

Q1 2023 13F Holders as of 31 Mar 2023

Type / Class
Equity / Common Stock
Shares outstanding
123,650,000
Total 13F shares
124,051,427
Share change
-4,328,726
Total reported value
$4,736,116,144
Put/Call ratio
39%
Price per share
$38.19
Number of holders
381
Value change
-$286,882,621
Number of buys
183
Number of sells
225

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 40637H109?
CUSIP 40637H109 identifies HALO - HALOZYME THERAPEUTICS, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of HALOZYME THERAPEUTICS, INC. - Common Stock (HALO) as of Q1 2023

As of 31 Mar 2023, HALOZYME THERAPEUTICS, INC. - Common Stock (HALO) was held by 381 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 124,051,427 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, Artisan Partners Limited Partnership, STATE STREET CORP, SNYDER CAPITAL MANAGEMENT L P, JPMORGAN CHASE & CO, Invesco Ltd., MACQUARIE GROUP LTD, GEODE CAPITAL MANAGEMENT, LLC, and GW&K Investment Management, LLC. This page lists 381 institutional shareholders reporting positions in this security for the Q1 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2023 vs Q4 2022 Across Filers

Q4 2022 holders
414
Q1 2023 holders
381
Holder diff
-33
Investor Q4 2022 Shares Q1 2023 Shares Share Diff Share Chg % Q4 2022 Value $ Q1 2023 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.